Shenzhen Kangtai Biological Products Co (SZSE:300601) Short-Term Debt & Capital Lease Obligation : ¥349 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Shenzhen Kangtai Biological Products Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥349 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Shenzhen Kangtai Biological Products Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,283 Mil.

Shenzhen Kangtai Biological Products Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Short-Term Debt & Capital Lease Obligation Chart

Shenzhen Kangtai Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt & Capital Lease Obligation

Get a 7-Day Free Trial

61.00

23.39

800.13

273.68

92.36

Shenzhen Kangtai Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial															272.90	280.63	182.78	92.36	349.43

Shenzhen Kangtai Biological Products Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Shenzhen Kangtai Biological Products Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Short-Term Debt & Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057

Website

http://www.biokangtai.com

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Executives

Liu Jian Kai	Directors, executives
Tao Jin	Secretary Dong
Zheng Hai Fa	Directors, executives
Zhou Hui	Executives
Miao Xiang	Directors, executives
Wen Fei Dong	Director
Du Wei Min	Directors, executives
Lv Zhi Yun	Supervisors
Gan Jian Hui	Executives
Zhu Zheng Yu	Executives
Liu Qun	Executives
Li Tong	Executives
Yuan Li Ping	Director
Li Xiang Ming	Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines